Skip to main content

Table 1 Demographic data of subjects

From: Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

Parameter

Sequence

N

Mean

SD

Median

Range

Age (years)

BE

20

23.9

3.65

23.5

20; 35

 

EA

20

25.1

5.01

24.0

20; 39

 

AEB

20

27.8

6.57

26.5

20; 45

Weight (kg)

BE

20

68.3

10.74

69.5

50; 90

 

EA

20

67.7

9.54

68.5

49; 82

 

AEB

20

67.9

10.48

68.0

52; 87

BMI (kg/m2) *

BE

20

22.8

2.40

23.0

19; 27

 

EA

20

22.9

2.29

23.0

19; 27

 

AEB

20

22.2

2.67

22.0

19; 27

 

Sequence

N

N (♀)

% (♀)

N (♂)

% (♂)

Female gender (%)

BE

20

7

35.0

13

65.0

 

EA

20

6

30.0

14

70.0

 

AEB

20

6

30.0

14

70.0

  1. Demography and other baseline characteristics by treatment sequence (Pharmacokinetic population; N = 60). "A" refers to Nurofen® forte, "B" refers to Migränin® and "E" refers to Eudorlin® extra. * calculated from measured height (m) and weight (kg).